thioredoxin

They are found in nearly all known organisms and are essential for life in mammals.{{cite journal | vauthors = Holmgren A | title = Thioredoxin and glutaredoxin systems | journal = The Journal of Biological Chemistry | volume = 264 | issue = 24 | pages = 13963–6 | date = August 1989 | doi = 10.1016/S0021-9258(18)71625-6 | pmid = 2668278 | url = http://www.jbc.org/cgi/reprint/264/24/13963.pdf | doi-access = free | access-date = 2007-02-23 | archive-date = 2007-09-29 | archive-url = https://web.archive.org/web/20070929121957/http://www.jbc.org/cgi/reprint/264/24/13963.pdf | url-status = dead }}{{cite journal | vauthors = Nordberg J, Arnér ES | title = Reactive oxygen species, antioxidants, and the mammalian thioredoxin system | journal = Free Radical Biology & Medicine | volume = 31 | issue = 11 | pages = 1287–312 | date = December 2001 | pmid = 11728801 | doi = 10.1016/S0891-5849(01)00724-9 }}

The primary function of thioredoxin (Trx) is the reduction of oxidized cysteine residues and the cleavage of disulfide bonds.{{cite journal | vauthors = Nakamura H, Nakamura K, Yodoi J | title = Redox regulation of cellular activation | journal = Annual Review of Immunology | volume = 15 | issue = 1 | pages = 351–69 | date = 1997-01-01 | pmid = 9143692 | doi = 10.1146/annurev.immunol.15.1.351 }} Multiple in vitro substrates for thioredoxin have been identified, including ribonuclease, choriogonadotropins, coagulation factors, glucocorticoid receptor, and insulin. Reduction of insulin is classically used as an activity test.{{cite web|url=https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=7295|title=Entrez Gene: TXN thioredoxin}} The thioredoxins are maintained in their reduced state by the flavoenzyme thioredoxin reductase, in a NADPH-dependent reaction.{{cite journal | vauthors = Mustacich D, Powis G | title = Thioredoxin reductase | journal = The Biochemical Journal | volume = 346 | issue = 1 | pages = 1–8 | date = February 2000 | pmid = 10657232 | pmc = 1220815 | doi = 10.1042/0264-6021:3460001 }} Thioredoxins act as electron donors to peroxidases and ribonucleotide reductase.{{cite journal | vauthors = Arnér ES, Holmgren A | title = Physiological functions of thioredoxin and thioredoxin reductase | journal = European Journal of Biochemistry | volume = 267 | issue = 20 | pages = 6102–9 | date = October 2000 | pmid = 11012661 | doi = 10.1046/j.1432-1327.2000.01701.x | doi-access = free }} The related glutaredoxins share many of the functions of thioredoxins, but are reduced by glutathione rather than a specific reductase.

Thioredoxin is a 12-kD oxidoreductase protein. Thioredoxin proteins also have a characteristic tertiary structure termed the thioredoxin fold. The active site contains a dithiols in a CXXC motif. These two cysteines are the key to the ability of thioredoxin to reduce other proteins.

For Trx1, this process begins by attack of Cys32, one of the residues conserved in the thioredoxin CXXC motif, onto the oxidized group of the substrate.{{cite journal | vauthors = Nagarajan N, Oka S, Sadoshima J | title = Modulation of signaling mechanisms in the heart by thioredoxin 1 | journal = Free Radical Biology & Medicine | date = December 2016 | pmid = 27993729 | doi = 10.1016/j.freeradbiomed.2016.12.020 | volume=109 | pmc=5462876 | pages=125–131}} Almost immediately after this event Cys35, the other conserved Cys residue in Trx1, forms a disulfide bond with Cys32, thereby transferring 2 electrons to the substrate which is now in its reduced form. Oxidized Trx1 is then reduced by thioredoxin reductase, which in turn is reduced by NADPH as described above. File:FigMech.png

Trx1 can regulate non-redox post-translational modifications.{{cite journal | vauthors = Liu T, Wu C, Jain MR, Nagarajan N, Yan L, Dai H, Cui C, Baykal A, Pan S, Ago T, Sadoshima J, Li H | title = Master redox regulator Trx1 upregulates SMYD1 & modulates lysine methylation | journal = Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics | volume = 1854 | issue = 12 | pages = 1816–1822 | date = December 2015 | pmid = 26410624 | doi = 10.1016/j.bbapap.2015.09.006 | pmc = 4721509 }} In the mice with cardiac-specific overexpression of Trx1, the proteomics study found that SET and MYND domain-containing protein 1 (SMYD1), a lysine methyltransferase highly expressed in cardiac and other muscle tissues, is also upregulated. This suggests that Trx1 may also play a role in protein methylation via regulating SMYD1 expression, which is independent of its oxidoreductase activity.

Plants have an unusually complex complement of Trx's composed of six well-defined types (Trxs f, m, x, y, h, and o) that reside in diverse cell compartments and function in an array of processes. Thioredoxin proteins move from cell to cell, representing a novel form of cellular communication in plants.

Thioredoxin has been shown to interact with:

• ASK1,{{cite journal | vauthors = Liu Y, Min W | title = Thioredoxin promotes ASK1 ubiquitination and degradation to inhibit ASK1-mediated apoptosis in a redox activity-independent manner | journal = Circulation Research | volume = 90 | issue = 12 | pages = 1259–66 | date = June 2002 | pmid = 12089063 | doi = 10.1161/01.res.0000022160.64355.62 | doi-access = free }}{{cite journal | vauthors = Morita K, Saitoh M, Tobiume K, Matsuura H, Enomoto S, Nishitoh H, Ichijo H | title = Negative feedback regulation of ASK1 by protein phosphatase 5 (PP5) in response to oxidative stress | journal = The EMBO Journal | volume = 20 | issue = 21 | pages = 6028–36 | date = November 2001 | pmid = 11689443 | pmc = 125685 | doi = 10.1093/emboj/20.21.6028 }}{{cite journal | vauthors = Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono K, Ichijo H | title = Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1 | journal = The EMBO Journal | volume = 17 | issue = 9 | pages = 2596–606 | date = May 1998 | pmid = 9564042 | pmc = 1170601 | doi = 10.1093/emboj/17.9.2596 }}
• Collagen, type I, alpha 1,{{cite journal | vauthors = Matsumoto K, Masutani H, Nishiyama A, Hashimoto S, Gon Y, Horie T, Yodoi J | title = C-propeptide region of human pro alpha 1 type 1 collagen interacts with thioredoxin | journal = Biochemical and Biophysical Research Communications | volume = 295 | issue = 3 | pages = 663–7 | date = July 2002 | pmid = 12099690 | doi = 10.1016/s0006-291x(02)00727-1 }}
• Glucocorticoid receptor,{{cite journal | vauthors = Makino Y, Yoshikawa N, Okamoto K, Hirota K, Yodoi J, Makino I, Tanaka H | title = Direct association with thioredoxin allows redox regulation of glucocorticoid receptor function | journal = The Journal of Biological Chemistry | volume = 274 | issue = 5 | pages = 3182–8 | date = January 1999 | pmid = 9915858 | doi = 10.1074/jbc.274.5.3182 | doi-access = free }}
• SENP1,{{cite journal | vauthors = Li X, Luo Y, Yu L, Lin Y, Luo D, Zhang H, He Y, Kim YO, Kim Y, Tang S, Min W | title = SENP1 mediates TNF-induced desumoylation and cytoplasmic translocation of HIPK1 to enhance ASK1-dependent apoptosis | journal = Cell Death and Differentiation | volume = 15 | issue = 4 | pages = 739–50 | date = April 2008 | pmid = 18219322 | doi = 10.1038/sj.cdd.4402303 | doi-access = free }}
• TXNIP.{{cite journal | vauthors = Nishiyama A, Matsui M, Iwata S, Hirota K, Masutani H, Nakamura H, Takagi Y, Sono H, Gon Y, Yodoi J | title = Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression | journal = The Journal of Biological Chemistry | volume = 274 | issue = 31 | pages = 21645–50 | date = July 1999 | pmid = 10419473 | doi = 10.1074/jbc.274.31.21645 | doi-access =free }}
• NF-κB – by reducing a disulfide bond in NF-κB, Trx1 promotes binding of this transcription factor to DNA.{{cite journal | vauthors = Matthews JR, Wakasugi N, Virelizier JL, Yodoi J, Hay RT | title = Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62 | journal = Nucleic Acids Research | volume = 20 | issue = 15 | pages = 3821–30 | date = August 1992 | pmid = 1508666 | pmc = 334054 | doi=10.1093/nar/20.15.3821}}
• AP1 via Ref1 – Trx1 indirectly increases the DNA-binding activity of activator protein 1 (AP1) by reducing the DNA repair enzyme redox factor 1 (Ref-1), which in turn reduces AP1 in an example of a redox regulation cascade.{{cite journal | vauthors = Hirota K, Matsui M, Iwata S, Nishiyama A, Mori K, Yodoi J | title = AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1 | language = en | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 94 | issue = 8 | pages = 3633–8 | date = April 1997 | pmid = 9108029 | pmc = 20492 | doi=10.1073/pnas.94.8.3633| bibcode = 1997PNAS...94.3633H | doi-access = free }}
• AMPK – AMPK function in cardiomyocytes is preserved during oxidative stress due to an interaction between AMPK and Trx1. By forming a disulfide bridge between the two proteins, Trx1 prevents the formation and aggregation of oxidized AMPK, thereby allowing AMPK to function normally and participate in signaling cascades.{{cite journal | vauthors = Shao D, Oka S, Liu T, Zhai P, Ago T, Sciarretta S, Li H, Sadoshima J | title = A redox-dependent mechanism for regulation of AMPK activation by Thioredoxin1 during energy starvation | journal = Cell Metabolism | volume = 19 | issue = 2 | pages = 232–45 | date = February 2014 | pmid = 24506865 | pmc = 3937768 | doi = 10.1016/j.cmet.2013.12.013 }}

Trx1 has been shown to downregulate cardiac hypertrophy, the thickening of the walls of the lower heart chambers, by interactions with several different targets. Trx1 upregulates the transcriptional activity of nuclear respiratory factors 1 and 2 (NRF1 and NRF2) and stimulates the expression of peroxisome proliferator-activated receptor γ coactivator 1-α (PGC-1α).{{cite journal | vauthors = Ago T, Yeh I, Yamamoto M, Schinke-Braun M, Brown JA, Tian B, Sadoshima J | title = Thioredoxin1 upregulates mitochondrial proteins related to oxidative phosphorylation and TCA cycle in the heart | journal = Antioxidants & Redox Signaling | volume = 8 | issue = 9–10 | pages = 1635–50 | pmid = 16987018 | doi = 10.1089/ars.2006.8.1635 | year=2006}}{{cite journal | vauthors = Yamamoto M, Yang G, Hong C, Liu J, Holle E, Yu X, Wagner T, Vatner SF, Sadoshima J | title = Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy | journal = The Journal of Clinical Investigation | volume = 112 | issue = 9 | pages = 1395–406 | date = November 2003 | pmid = 14597765 | pmc = 228400 | doi = 10.1172/JCI17700 }} Furthermore, Trx1 reduces two cysteine residues in histone deacetylase 4 (HDAC4), which allows HDAC4 to be imported from the cytosol, where the oxidized form resides,{{cite journal | vauthors = Matsushima S, Kuroda J, Ago T, Zhai P, Park JY, Xie LH, Tian B, Sadoshima J | title = Increased oxidative stress in the nucleus caused by Nox4 mediates oxidation of HDAC4 and cardiac hypertrophy | language = en | journal = Circulation Research | volume = 112 | issue = 4 | pages = 651–63 | date = February 2013 | pmid = 23271793 | pmc = 3574183 | doi = 10.1161/CIRCRESAHA.112.279760 }} into the nucleus.{{cite journal | vauthors = Ago T, Liu T, Zhai P, Chen W, Li H, Molkentin JD, Vatner SF, Sadoshima J | title = A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy | journal = Cell | volume = 133 | issue = 6 | pages = 978–93 | date = June 2008 | pmid = 18555775 | doi = 10.1016/j.cell.2008.04.041 | s2cid = 2678474 | doi-access = free }} Once in the nucleus, reduced HDAC4 downregulates the activity of transcription factors such as NFAT that mediate cardiac hypertrophy. Trx 1 also controls microRNA levels in the heart and has been found to inhibit cardiac hypertrophy by upregulating miR-98/let-7.{{cite journal | vauthors = Yang Y, Ago T, Zhai P, Abdellatif M, Sadoshima J | title = Thioredoxin 1 negatively regulates angiotensin II-induced cardiac hypertrophy through upregulation of miR-98/let-7 | language = en | journal = Circulation Research | volume = 108 | issue = 3 | pages = 305–13 | date = February 2011 | pmid = 21183740 | pmc = 3249645 | doi = 10.1161/CIRCRESAHA.110.228437 }} Trx1 can regulate the expression level of SMYD1, thus may indirectly modulate protein methylation for purpose of cardiac protection.

Thioredoxin is used in skin care products as an antioxidant in conjunction with glutaredoxin and glutathione.{{citation needed|date=July 2019}}

NrdH from Mycobacterium tuberculosis is a distinctive thioredoxin-like protein, functionally similar to thioredoxins but with a sequence more akin to glutaredoxins. Unlike typical glutaredoxins, NrdH can accept electrons from thioredoxin reductase (TrxR) to drive ribonucleotide reduction, a critical step in DNA synthesis. Structural analysis reveals a thioredoxin fold with conserved redox motifs—CVQC and WSGFRP—that form a hydrogen-bond network and hydrophobic patch, stabilizing TrxR binding.{{Cite journal |last=Phulera |first=Swastik |last2=Mande |first2=Shekhar C. |date=2013-06-11 |title=The Crystal Structure of Mycobacterium tuberculosis NrdH at 0.87 Å Suggests a Possible Mode of Its Activity |url=https://pubs.acs.org/doi/10.1021/bi400191z |journal=Biochemistry |language=en |volume=52 |issue=23 |pages=4056–4065 |doi=10.1021/bi400191z |issn=0006-2960|url-access=subscription }} This unique blend of glutaredoxin sequence features with thioredoxin activity underscores NrdH's adaptive role in M. tuberculosis' redox regulation.

• RuBisCO - enzyme activity regulated by thioredoxin
• Peroxiredoxin - enzyme activity regulated by thioredoxin
• Thioredoxin fold
• Thioredoxin reductase

{{Clear}}

{{Reflist}}

{{Refbegin|30em}}

• {{cite journal | vauthors = Arnér ES, Holmgren A | title = Physiological functions of thioredoxin and thioredoxin reductase | journal = European Journal of Biochemistry | volume = 267 | issue = 20 | pages = 6102–9 | date = October 2000 | pmid = 11012661 | doi = 10.1046/j.1432-1327.2000.01701.x | doi-access = free }}
• {{cite journal | vauthors = Nishinaka Y, Masutani H, Nakamura H, Yodoi J | title = Regulatory roles of thioredoxin in oxidative stress-induced cellular responses | journal = Redox Report | volume = 6 | issue = 5 | pages = 289–95 | year = 2002 | pmid = 11778846 | doi = 10.1179/135100001101536427 | s2cid = 34079507 }}
• {{cite journal | vauthors = Ago T, Sadoshima J | title = Thioredoxin and ventricular remodeling | journal = Journal of Molecular and Cellular Cardiology | volume = 41 | issue = 5 | pages = 762–73 | date = November 2006 | pmid = 17007870 | pmc = 1852508 | doi = 10.1016/j.yjmcc.2006.08.006 }}
• {{cite journal | vauthors = Tonissen KF, Wells JR | title = Isolation and characterization of human thioredoxin-encoding genes | journal = Gene | volume = 102 | issue = 2 | pages = 221–8 | date = June 1991 | pmid = 1874447 | doi = 10.1016/0378-1119(91)90081-L }}
• {{cite journal | vauthors = Martin H, Dean M | title = Identification of a thioredoxin-related protein associated with plasma membranes | journal = Biochemical and Biophysical Research Communications | volume = 175 | issue = 1 | pages = 123–8 | date = February 1991 | pmid = 1998498 | doi = 10.1016/S0006-291X(05)81209-4 }}
• {{cite journal | vauthors = Forman-Kay JD, Clore GM, Wingfield PT, Gronenborn AM | title = High-resolution three-dimensional structure of reduced recombinant human thioredoxin in solution | journal = Biochemistry | volume = 30 | issue = 10 | pages = 2685–98 | date = March 1991 | pmid = 2001356 | doi = 10.1021/bi00224a017 }}
• {{cite journal | vauthors = Jacquot JP, de Lamotte F, Fontecave M, Schürmann P, Decottignies P, Miginiac-Maslow M, Wollman E | title = Human thioredoxin reactivity-structure/function relationship | journal = Biochemical and Biophysical Research Communications | volume = 173 | issue = 3 | pages = 1375–81 | date = December 1990 | pmid = 2176490 | doi = 10.1016/S0006-291X(05)80940-4 }}
• {{cite journal | vauthors = Forman-Kay JD, Clore GM, Driscoll PC, Wingfield P, Richards FM, Gronenborn AM | title = A proton nuclear magnetic resonance assignment and secondary structure determination of recombinant human thioredoxin | journal = Biochemistry | volume = 28 | issue = 17 | pages = 7088–97 | date = August 1989 | pmid = 2684271 | doi = 10.1021/bi00443a045 }}
• {{cite journal | vauthors = Tagaya Y, Maeda Y, Mitsui A, Kondo N, Matsui H, Hamuro J, Brown N, Arai K, Yokota T, Wakasugi H | title = ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction | journal = The EMBO Journal | volume = 8 | issue = 3 | pages = 757–64 | date = March 1989 | pmid = 2785919 | pmc = 400872 | doi = 10.1002/j.1460-2075.1989.tb03436.x}}
• {{cite journal | vauthors = Wollman EE, d'Auriol L, Rimsky L, Shaw A, Jacquot JP, Wingfield P, Graber P, Dessarps F, Robin P, Galibert F | title = Cloning and expression of a cDNA for human thioredoxin | journal = The Journal of Biological Chemistry | volume = 263 | issue = 30 | pages = 15506–12 | date = October 1988 | doi = 10.1016/S0021-9258(19)37617-3 | pmid = 3170595 | doi-access = free }}
• {{cite journal | vauthors = Heppell-Parton A, Cahn A, Bench A, Lowe N, Lehrach H, Zehetner G, Rabbitts P | title = Thioredoxin, a mediator of growth inhibition, maps to 9q31 | journal = Genomics | volume = 26 | issue = 2 | pages = 379–81 | date = March 1995 | pmid = 7601465 | doi = 10.1016/0888-7543(95)80223-9 }}
• {{cite journal | vauthors = Qin J, Clore GM, Kennedy WM, Huth JR, Gronenborn AM | title = Solution structure of human thioredoxin in a mixed disulfide intermediate complex with its target peptide from the transcription factor NF kappa B | journal = Structure | volume = 3 | issue = 3 | pages = 289–97 | date = March 1995 | pmid = 7788295 | doi = 10.1016/S0969-2126(01)00159-9 | doi-access = free }}
• {{cite journal | vauthors = Kato S, Sekine S, Oh SW, Kim NS, Umezawa Y, Abe N, Yokoyama-Kobayashi M, Aoki T | title = Construction of a human full-length cDNA bank | journal = Gene | volume = 150 | issue = 2 | pages = 243–50 | date = December 1994 | pmid = 7821789 | doi = 10.1016/0378-1119(94)90433-2 }}
• {{cite journal | vauthors = Qin J, Clore GM, Gronenborn AM | title = The high-resolution three-dimensional solution structures of the oxidized and reduced states of human thioredoxin | journal = Structure | volume = 2 | issue = 6 | pages = 503–22 | date = June 1994 | pmid = 7922028 | doi = 10.1016/S0969-2126(00)00051-4 | doi-access = free }}
• {{cite journal | vauthors = Gasdaska PY, Oblong JE, Cotgreave IA, Powis G | title = The predicted amino acid sequence of human thioredoxin is identical to that of the autocrine growth factor human adult T-cell derived factor (ADF): thioredoxin mRNA is elevated in some human tumors | journal = Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression | volume = 1218 | issue = 3 | pages = 292–6 | date = August 1994 | pmid = 8049254 | doi = 10.1016/0167-4781(94)90180-5 }}
• {{cite journal | vauthors = Qin J, Clore GM, Kennedy WP, Kuszewski J, Gronenborn AM | title = The solution structure of human thioredoxin complexed with its target from Ref-1 reveals peptide chain reversal | journal = Structure | volume = 4 | issue = 5 | pages = 613–20 | date = May 1996 | pmid = 8736558 | doi = 10.1016/S0969-2126(96)00065-2 | doi-access = free }}
• {{cite journal | vauthors = Weichsel A, Gasdaska JR, Powis G, Montfort WR | title = Crystal structures of reduced, oxidized, and mutated human thioredoxins: evidence for a regulatory homodimer | journal = Structure | volume = 4 | issue = 6 | pages = 735–51 | date = June 1996 | pmid = 8805557 | doi = 10.1016/S0969-2126(96)00079-2 | doi-access = free }}
• {{cite journal | vauthors = Andersen JF, Sanders DA, Gasdaska JR, Weichsel A, Powis G, Montfort WR | title = Human thioredoxin homodimers: regulation by pH, role of aspartate 60, and crystal structure of the aspartate 60 --> asparagine mutant | journal = Biochemistry | volume = 36 | issue = 46 | pages = 13979–88 | date = November 1997 | pmid = 9369469 | doi = 10.1021/bi971004s }}
• {{cite journal | vauthors = Maruyama T, Kitaoka Y, Sachi Y, Nakanoin K, Hirota K, Shiozawa T, Yoshimura Y, Fujii S, Yodoi J | title = Thioredoxin expression in the human endometrium during the menstrual cycle | journal = Molecular Human Reproduction | volume = 3 | issue = 11 | pages = 989–93 | date = November 1997 | pmid = 9433926 | doi = 10.1093/molehr/3.11.989 | doi-access = free }}
• {{cite journal | vauthors = Sahlin L, Stjernholm Y, Holmgren A, Ekman G, Eriksson H | title = The expression of thioredoxin mRNA is increased in the human cervix during pregnancy | journal = Molecular Human Reproduction | volume = 3 | issue = 12 | pages = 1113–7 | date = December 1997 | pmid = 9464857 | doi = 10.1093/molehr/3.12.1113 | doi-access = free }}
• {{cite journal | vauthors = Maeda K, Hägglund P, Finnie C, Svensson B, Henriksen A | title = Structural basis for target protein recognition by the protein disulfide reductase thioredoxin | journal = Structure | volume = 14 | issue = 11 | pages = 1701–10 | date = November 2006 | pmid = 17098195 | doi = 10.1016/j.str.2006.09.012 | doi-access = free }}

{{Refend}}

• {{MeshName|Thioredoxin}}
• {{PDBe-KB2|P10599|Thioredoxin}}

{{PDB Gallery|geneid=7295}}

Category:Single-pass transmembrane proteins

Category:Moonlighting proteins